RPS24P18

Across TCGA pan-cancer cohorts, RPS24P18 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPS24P18 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPS24P18 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS24P18 expression acts as an unfavorable survival marker, although some lineages such as THCA and MESO show a favorable association.

KIRC, ACC, and STAD are the cancer types where RPS24P18 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	III,IV	0.496	0.693	<.001	133	view →
ACC	DFS	Tertile	II,III,IV	0.298	0.686	<.001	87	view →
STAD	DFS	Median	II,III,IV	0.572	0.707	.006	33	view →
THCA	DFS	Tertile	All	1.000	0.877	.005	31	view →
MESO	DFS	Tertile	III,IV	0.783	0.279	.005	27	view →
SKCM	OS	Tertile	II,III,IV	0.222	0.421	.016	21	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	21	view →
LUSC	OS	Tertile	II,III,IV	0.746	0.571	.015	21	view →
LIHC	OS	Tertile	All	0.634	0.786	.043	12	view →
CESC	OS	Tertile	All	0.799	0.522	.028	6	view →
ESCA	OS	Median	All	1.000	0.543	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPS24P18–KIRC (DFS)

Open the KIRC breakdown →